Skip to main content

What the FDA labels say about taking them together

Fosamprenavir and raltegravir

Fosamprenavir's FDA label of September 15, 2023 names raltegravir in its drug interactions section; the raltegravir labels PlainMeds reads (2) do not name fosamprenavir.

Check it at the source: the fosamprenavir FDA label on DailyMed (effective September 15, 2023, Mylan Pharmaceuticals Inc.); the raltegravir FDA label on DailyMed (effective October 18, 2024, Merck Sharp & Dohme LLC).

What does the fosamprenavir label say about raltegravir?

Fosamprenavir label, drug interactions

Concomitant Drug Class/Drug Name: HIV integrase inhibitor: Raltegravir; Effect on Concentration of Amprenavir or Concomitant Drug: Fosamprenavir: ↓ Amprenavir ↓ Raltegravir Fosamprenavir/ ritonavir: ↓ Amprenavir ↓ Raltegravir; Clinical Comment: Appropriate doses of the combination with respect to safety and efficacy have not been established.

Source: FDA drug label (Fosamprenavir Calcium), Mylan Pharmaceuticals Inc., effective September 15, 2023 (SPL set 3a1424d8-844c-4e24-9ebd-b2c2b61b61a3), via openFDA; the full label on DailyMed

What does the raltegravir label say about fosamprenavir?

Raltegravir's label (effective October 18, 2024) and its 1 other brand-application label do not name fosamprenavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (ISENTRESS), Merck Sharp & Dohme LLC, effective October 18, 2024 (SPL set 89a5ec53-d956-4329-8004-0f40f51c88a3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

2Fosamprenavir generic labelers
1Raltegravir generic labelers
FosamprenavirRaltegravir
Labeled forHIVHIV
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$34.54 per tablet 400 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?